JADBio Accelerate Biomarker Discovery – AutoML is a machine learning tool that automates the discovery of biomarkers without the need for coding. It uses auto machine learning to interpret the role of biomarkers based on the specific research needs. The tool is available in the AWS Marketplace and can be used for accelerating drug discovery times and costs by leveraging technology to optimize the discovery process. The platform can parse multi-omics data types such as genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images. This enables researchers to quickly and efficiently obtain insights needed for research. The tool has been used for early biomarker discovery, drug repurposing, and understanding response to treatment, among others. The tool also features no-code machine learning that enables users to automate biomarker discovery that is relevant to their research needs. The company provides a wide range of support materials such as case studies, webinars, and a glossary to make it easier for researchers to get started with the platform. JADBio also has partnerships with trusted companies such as Indivumed, QIAGEN, Ledidi, BioLizard, and Elucidata. Researchers can sign up for a free JADBio AutoML account to start using the tool.
